Source comparison
Is CJC-1295 No DAC & Ipamorelin Safe vs Synthetic Growth Hormone?
Mechanism Stimulates endogenous pituitary GH release in natural pulses Replaces natural GH with constant exogenous supply Peptides preserve physiological feedback loops; rhGH overrides them Side Effect Incidence 15–30% experience mild transient effects (water
This comparison does not assign a generated winner or score.
- Mechanism
- Stimulates endogenous pituitary GH release in natural pulses
- Replaces natural GH with constant exogenous supply
- Peptides preserve physiological feedback loops; rhGH overrides them
- Side Effect Incidence
- 15–30% experience mild transient effects (water retention, headaches)
- 40–60% report joint pain, carpal tunnel, insulin resistance
- Peptides demonstrate significantly lower adverse event rate
- Insulin Sensitivity Impact
- Minimal impact; IGF-1 elevation occurs within physiological range
- Can induce insulin resistance at therapeutic doses (>2 IU/day)
- Peptides safer for metabolic health long-term
- Cost Per Month (Research Grade)
- $80–$150 for combined protocol (300mcg CJC + 300mcg Ipa daily)
- $400–$800 for 4–6 IU daily rhGH
- Peptides offer 70–80% cost reduction
- Regulatory Status
- Research-grade peptides available from 503B facilities
- Requires prescription for approved indications only
- Peptides occupy legal grey area; rhGH is controlled
- Professional Assessment
- Peptides mimic natural GH pulsatility with fewer systemic complications. Preferred for research exploring physiological GH optimization without replacement therapy risks
- rhGH appropriate for diagnosed GH deficiency but introduces supraphysiological hormone levels that carry metabolic and structural risks peptides avoid